NCT00677833 - Azithromycin Plus Chloroquine Versus Artemether-Lumefantrine For The Treatment Of Uncomplicated P. Falciparum Malaria In Children In Africa | Biotech Hunter

Enrollment

361

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions

Malaria, Falciparum

Interventions

DRUG

Azithromycin plus Chloroquine

Combination of Azithromycin plus Chloroquine Azithromycin (\~30 mg/kg) + chloroquine (\~10mg base /kg) combination tablet(s) on weight basis, once daily for 3 days (Days 0,1,2) or Artemether-lumefantrine tablet(s) based on weight and labeling for 3 days (Days 0, 1, 2)

DRUG

Artemether-lumefantrine

Artemether-lumefantrine tablet(s) based on weight and labeling for 3 days (Days 0, 1, 2)

Trial Locations (7)

40100

Pfizer Investigational Site, Kisumu

Unknown

Pfizer Investigational Site, Nouna

Pfizer Investigational Site, Ouagadougou

Pfizer Investigational Site, Abidjan

Pfizer Investigational Site, Navrongo

Pfizer Investigational Site, Bamako

Pfizer Investigational Site, Sikasso